Cargando…
Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation
Lipid nanocarriers are becoming a versatile platform for oral delivery of lipophilic drugs. In this article, we aimed to explore the gastrointestinal behaviors of lipid nanoparticles and the effect of PEGylation on oral absorption of fenofibrate (FN), a Biopharmaceutics Classification System (BCS) I...
Autores principales: | Zhang, Xingwang, Chen, Guijiang, Zhang, Tianpeng, Ma, Zhiguo, Wu, Baojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251747/ https://www.ncbi.nlm.nih.gov/pubmed/25473287 http://dx.doi.org/10.2147/IJN.S73340 |
Ejemplares similares
-
Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS
por: Ye, Jingyi, et al.
Publicado: (2019) -
The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
por: Yaghoobian, Morteza, et al.
Publicado: (2020) -
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
por: Markovic, Milica, et al.
Publicado: (2020) -
On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet
por: Kushwah, Varun, et al.
Publicado: (2021) -
Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes
por: Chen, Zhongjian, et al.
Publicado: (2016)